# A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial

> **NCT03344458** · PHASE3 · COMPLETED · sponsor: **Ascendis Pharma A/S** · enrollment: 298 (actual)

## Conditions studied

- Growth Hormone Deficiency, Pediatric
- Endocrine System Diseases
- Hormone Deficiency
- Pituitary Diseases

## Interventions

- **DRUG:** TransCon hGH

## Key facts

- **NCT ID:** NCT03344458
- **Lead sponsor:** Ascendis Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-19
- **Primary completion:** 2023-02-21
- **Final completion:** 2023-02-21
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03344458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03344458, "A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03344458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*